6O
6OM.F Owens & Minor Inc
- Market cap
- EUR 8.77M
- P/E
- -
- P/B
- 1.41x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 6OM.F undervalued?
Graham numberThe Graham number of Owens & Minor Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Owens & Minor Inc fundamental analysis
No fundamental analysis for Owens & Minor Inc yet.
Owens & Minor Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Owens & Minor Inc
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also su…
Full company profileOwens & Minor Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Owens & Minor Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 9.72B | 9.32B | 9.84B | 9.21B | 8.48B | 9.79B | 9.96B | 2.55B | 2.68B | 2.76B | 2.46B |
| Gross Profit | 1.19B | 1.17B | 1.37B | 1.13B | 1.28B | 1.51B | 1.83B | 1.22B | 1.28B | 1.29B | 1.07B |
| Operating Income | 224M | 150M | 110M | 103M | 242M | 403M | 198M | 215M | 198M | 222M | 72.7M |
| EBITDA | - | 149M | -290M | 186M | 287M | 415M | 368M | 342M | -41.0M | 220M | 174M |
| Net Income | 109M | 72.8M | -437M | -62.4M | 29.9M | 222M | 22.4M | -41.3M | -363M | -1.10B | -154M |
| EPS | - | 1.18 | -7.02 | -0.99 | 0.41 | 2.94 | 0.29 | -0.54 | -4.70 | -14 | -2.00 |
| Balance Sheet | |||||||||||
| Total Assets | 2.72B | 3.38B | 3.77B | 3.64B | 3.34B | 3.54B | 5.39B | 5.09B | 4.66B | 2.45B | 2.08B |
| Total Liabilities | 1.76B | 2.36B | 3.26B | 3.18B | 2.62B | 2.60B | 4.44B | 4.17B | 4.09B | 2.91B | 2.65B |
| Shareholders' Equity | 960M | 1.02B | 518M | 462M | 712M | 939M | 946M | 924M | 565M | -461M | -568M |
| Cash & Short-term Investments | 185M | 105M | 103M | 67.0M | 83.1M | 55.7M | 69.5M | 243M | 49.4M | 282M | 26.6M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 188M | 56.8M | 116M | 166M | 339M | 124M | 325M | 716M | 161M | -102M | -125M |
| Capital Expenditure | 30.1M | 34.6M | 44.9M | 42.4M | 50.4M | 41.0M | 158M | 203M | 183M | 201M | 175M |
| Free Cash Flow | - | 6.04M | 49.9M | 114M | 280M | 74.5M | 158M | 513M | -21.2M | -303M | -300M |
| Ratios | |||||||||||
| ROE | 11.3% | 7.2% | -84.3% | -13.5% | 4.2% | 23.6% | 2.4% | -4.5% | -64.2% | - | - |
| ROA | 4.0% | 2.2% | -11.6% | -1.7% | 0.9% | 6.3% | 0.4% | -0.8% | -7.8% | -44.9% | -7.4% |
| Net Profit Margin | 1.1% | 0.8% | -4.4% | -0.7% | 0.4% | 2.3% | 0.2% | -1.6% | -13.5% | -39.8% | -6.3% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Owens & Minor Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Dec 14, 2021
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | USD 183K | 0.00 | 0.8% |
| 2021 | USD 731K | 0.01 | 0.3% |
| 2020 | USD 648K | 0.01 | 2.2% |
| 2019 | USD 5.23M | 0.08 | - |
| 2018 | USD 48.2M | 0.77 | - |
| 2017 | USD 63.2M | 1.03 | 86.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Owens & Minor Inc
- Insiders 7.28%
- Institutions 81.91%
- Public & others 10.80%
- Shares outstanding 76.9M
- Free float 56.2M
Owens & Minor Inc company profile
- Company name
- Owens & Minor Inc
- Ticker
- 6OM.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 6,500
- Fiscal year end
- December
- Address
- 4435 Waterfront Drive, Glen Allen, VA, United States, 23060
- Phone
- (804) 277-4304
- Website
- accendrahealth.com
About Owens & Minor Inc
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.
Owens & Minor Inc management
10- Mr. Kenneth Gardner-SmithPresident, CEO & Director · born 1981
- Mr. Jonathan A. LeonExecutive VP, CFO & Corporate Treasurer · born 1967
- Mr. Nicholas PiecoraSenior VP & Chief Information Officer
- Will ParrishVP of Strategy, Corporate Development, & IR
- Ms. Carrie ChildressExecutive VP & Chief Marketing Officer
- Mr. Dirk BensonChief Commercial Officer
- Mr. Colin BainChief Products Officer
- Ms. Agnes AnsayVP & Chief Procurement Officer
- Mr. Scott LloydChief Commercial Officer
- Trudi AllcottDirector of Media Relations